FDA Delays Action on Johnson & Johnson (JOBS) Seizure Drug Published: Aug 24, 2009 AP — Johnson & Johnson has reported that federal health regulators have delayed a decision on its experimental seizure drug carisbamate. Related links Pharma Times [Free Reg Req'd] This will open in a new window Bloomberg This will open in a new window News Release This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news